SPONSOR
Aparna Goel
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Primary Sclerosing Cholangitis
Aparna Goel is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Primary Sclerosing Cholangitis.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Aparna Goel
How many clinical trials has Aparna Goel sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Aparna Goel, of which 1 are actively recruiting participants. These trials cover conditions including Primary Sclerosing Cholangitis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Aparna Goel research focus on?
Aparna Goel clinical trials span Primary Sclerosing Cholangitis. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Aparna Goel clinical trial?
To participate in a Aparna Goel trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Aparna Goel trials with current recruitment status updated daily.
Clinical Trials by Aparna Goel
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology